Cargando…

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy

Contrast-induced nephropathy (CIN) is common. Risk factors include preexisting renal impairment, diabetes, elderly age, and dehydration. In a single-centre prospective study, we investigated which factors are implicated for CIN in patients with peripheral arterial disease due for angiography. Serum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabeer, Muhammad Asif, Cross, Jennifer, Hamilton, George, Rashid, Sheikh Tawqeer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Contrast-Induced Nephropathy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859667/ https://www.ncbi.nlm.nih.gov/pubmed/33228378 http://dx.doi.org/10.1177/0003319720969536

Ejemplares similares

Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
por: Hanna, Ramy M, et al.
Publicado: (2018)

Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018)

Pembrolizumab-related renal toxicities: diagnosis first, treatment later
por: Sprangers, Ben
Publicado: (2018)

Renal toxicities associated with pembrolizumab
por: Izzedine, Hassan, et al.
Publicado: (2018)

A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy
por: Tziastoudi, Maria, et al.
Publicado: (2017)

Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines
por: van der Molen, Aart J., et al.
Publicado: (2018)

Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience
por: Meurer, Karoline, et al.
Publicado: (2015)

Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events
por: Cheng, Wei, et al.
Publicado: (2020)

Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines
por: Roditi, Giles, et al.
Publicado: (2022)

Minimal risk of contrast-induced kidney injury in a randomly selected cohort with mildly reduced GFR
por: Carlqvist, Jeanette, et al.
Publicado: (2020)

Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines
por: Stacul, Fulvio, et al.
Publicado: (2017)

Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines
por: van der Molen, Aart J., et al.
Publicado: (2018)

Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose
por: Rutten, Annemarieke, et al.
Publicado: (2010)

Oxalate nephropathy is a major cause of kidney injury in surgically treated pancreatic adenocarcinoma patients
por: Desbuissons, Geoffroy, et al.
Publicado: (2019)

Impact on clinical practice of updated guidelines on iodinated contrast material: CINART
por: Nijssen, E. C., et al.
Publicado: (2020)

Risk of acute kidney injury after contrast-enhanced computerized tomography: a systematic review and meta-analysis of 21 propensity score–matched cohort studies
por: Obed, Mikal, et al.
Publicado: (2022)

Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?
por: Mosler, Frank, et al.
Publicado: (2021)

Podocyturia: why it may have added value in rare diseases
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2018)

New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
por: Mignani, Renzo, et al.
Publicado: (2018)

Will the FAbry STabilization indEX make its way to everyday clinical practice?
por: Cairns, Tereza, et al.
Publicado: (2018)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease
por: Edwards, Marie E, et al.
Publicado: (2018)

MYH9-related disorders display heterogeneous kidney involvement and outcome
por: Tabibzadeh, Nahid, et al.
Publicado: (2018)

MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy
por: Fernandez-Prado, Raul, et al.
Publicado: (2019)

Changes in metformin use in chronic kidney disease
por: Imam, Talha H.
Publicado: (2017)

A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis
por: Imai, Eri, et al.
Publicado: (2016)

Familial vasculitides: granulomatosis with polyangitis and microscopic polyangitis in two brothers with differing anti-neutrophil cytoplasm antibody specificity
por: Prendecki, Maria, et al.
Publicado: (2016)

Machine learning-based prediction of insufficient contrast enhancement in coronary computed tomography angiography
por: Lopes, R. R., et al.
Publicado: (2022)

ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
por: Neri, E., et al.
Publicado: (2015)

Prospective multicenter assessment of patient preferences for properties of gadolinium-based contrast media and their potential socioeconomic impact in a screening breast MRI setting
por: Woolen, Sean A., et al.
Publicado: (2021)

No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT
por: Kooiman, Judith, et al.
Publicado: (2015)

The pharmacokinetic profile, tolerability and safety of the iodinated, non-ionic, dimeric contrast medium Iosimenol 340 injection in healthy human subjects
por: Meurer, Karoline, et al.
Publicado: (2015)

Contrast agent and radiation dose reduction in abdominal CT by a combination of low tube voltage and advanced image reconstruction algorithms
por: Buls, Nico, et al.
Publicado: (2014)

Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue
por: Jost, Gregor, et al.
Publicado: (2016)

A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2—intra-arterial administration
por: van der Molen, Aart J., et al.
Publicado: (2022)

Spontaneous Echocardiographic Contrast in Constrictive Pericarditis
por: Balakrishnan, Kuhendra, et al.
Publicado: (2017)

Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial
por: Achenbach, Stephan, et al.
Publicado: (2016)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is needed for most high-risk patients
por: Lee, Byron K.
Publicado: (2020)

Left atrial appendage occlusion should be offered only to select atrial fibrillation patients
por: Munir, Muhammad Bilal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_er8gmqpjtl25j0kroc8ivn2i7m